First knowledge of the Russian COVID-19 vaccine for peer review

September Four (UPI) – Critical knowledge for the COVID-19 vaccine announced through Russia last month published Friday in a primary medical journal for clinical review, a key step in the approval process.

The vaccine a reaction of antibodies in all participants, he added, as well as reactions in T cells and neutralizing antibodies in 28 days.

Russia announced the vaccine last month and said it had registered for use, the first COVID-19 vaccine in the world to do so.Russian President Vladimir Putin said he even gave it to one of his daughters.

However, this announcement was criticized by top fitness experts because none of the knowledge had been published and no major tests had been conducted in the later stages of the vaccine.

“I hope the Russians have definitely shown that the vaccine is effective,” he said.”I seriously doubt they did.”

Russian scientists said late last month that they were presenting peer-reviewed publication verification information and that a new circular of verifications involving another 40,000 people had begun.The first effects of these trials are expected in October or November.

Kirill Dmitriev, executive director of the Russian Direct Investment Fund, which helped fund the progression of the vaccine, said the published effects were “the definitive answer to the series of questions directed against Russia.”

Leave a Comment

Your email address will not be published. Required fields are marked *